tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Stringer, 345 are a BUY (98.01%), 7 are a HOLD (1.99%).
Analyst Joseph Stringer, currently employed at NEEDHAM, carries an average stock price target met ratio of 41.2% that have a potential upside of 38.47% achieved within 234 days.
Joseph Stringer’s has documented 671 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PCVX, Vaxcyte at 25-Sep-2026.
Analyst best performing recommendations are on CDTX (CIDARA THERAPEUTICS).
The best stock recommendation documented was for CDTX (CIDARA THERAPEUTICS) at 11/7/2025. The price target of $135 was fulfilled within 7 days with a profit of $30.61 (29.32%) receiving and performance score of 41.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-May-2026
$31
4 months 19 days ago
(15-May-2026)
4/22 (18.18%)
$13.11 (73.28%)
308
Buy Since 20-Jan-2026
$41
$37.23 (987.53%)
$26
5 months 17 days ago
(17-Apr-2026)
15/18 (83.33%)
$0.1 (0.24%)
100
Hold Since 02-Nov-2023
$41
$37.23 (987.53%)
$20
6 months 2 days ago
(02-Apr-2026)
14/19 (73.68%)
$0.59 (1.46%)
147
Buy Since 19-Jul-2022
$41
$37.23 (987.53%)
$48
6 months 3 days ago
(01-Apr-2026)
4/29 (13.79%)
$0.61 (1.51%)
90
Buy Since 19-Jan-2024
$41
$37.23 (987.53%)
$45
6 months 3 days ago
(01-Apr-2026)
16/28 (57.14%)
$0.61 (1.51%)
368
Which stock is Joseph Stringer most bullish on?
Which stock is Joseph Stringer most reserved on?
What Year was the first public recommendation made by Joseph Stringer?
